Nephros (NEPH) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.08% |
| Dec 31, 2025 | 7.44% |
| Sep 30, 2025 | 5.33% |
| Jun 30, 2025 | -6.45% |
| Mar 31, 2025 | -8.80% |
| Dec 31, 2024 | -14.04% |
| Sep 30, 2024 | -16.47% |
| Jun 30, 2024 | -14.87% |
| Mar 31, 2024 | -13.98% |
| Dec 31, 2023 | -13.79% |
| Sep 30, 2023 | -10.52% |
| Jun 30, 2023 | -14.55% |
| Mar 31, 2023 | -15.78% |
| Dec 31, 2022 | -1.84% |
| Sep 30, 2022 | -0.64% |
| Jun 30, 2022 | 7.57% |
| Mar 31, 2022 | 15.27% |
| Dec 31, 2021 | 18.68% |
| Sep 30, 2021 | 23.75% |
| Jun 30, 2021 | 38.00% |
| Mar 31, 2021 | 57.03% |
| Dec 31, 2020 | 54.87% |
| Sep 30, 2020 | 75.41% |
| Jun 30, 2020 | 80.29% |
| Mar 31, 2020 | 77.36% |
| Dec 31, 2019 | 63.15% |
| Sep 30, 2019 | 56.57% |
| Jun 30, 2019 | 44.34% |
| Mar 31, 2019 | 43.55% |
| Dec 31, 2018 | 38.55% |
| Sep 30, 2018 | 29.75% |
| Jun 30, 2018 | 26.38% |
| Mar 31, 2018 | 20.89% |
| Dec 31, 2017 | 13.94% |
| Sep 30, 2017 | -3.11% |
| Jun 30, 2017 | 6.50% |
| Mar 31, 2017 | 2.34% |
| Dec 31, 2016 | -2.50% |
| Sep 30, 2016 | 5.60% |
| Jun 30, 2016 | 11.50% |
| Mar 31, 2016 | 7.78% |
| Dec 31, 2015 | 4.01% |
| Sep 30, 2015 | 2.86% |
| Jun 30, 2015 | -7.96% |
| Mar 31, 2015 | -10.02% |
| Dec 31, 2014 | -5.51% |
| Sep 30, 2014 | 2.48% |
| Jun 30, 2014 | -5.58% |
| Dec 31, 2013 | 22.03% |